EVALUATING IN VIVO MODELS IN PRECLINICAL DRUG DEVELOPMENT

In vivo models are essential tools during preclinical drug development, allowing researchers to assess the efficacy and safety of novel drugs in a living organism. Selecting the appropriate model is essential to confirm applicable preclinical findings. This involves a meticulous understanding of the disease being studied, as well as the constraints